Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts

Am J Obstet Gynecol. 2003 Oct;189(4):1155-60. doi: 10.1067/s0002-9378(03)00592-1.

Abstract

Objective: This study was undertaken to investigate the involvement of maternal and infant B vitamins and homocysteine as risk factors for orofacial clefting.

Study design: Venous blood samples were taken from 96 infants with nonsyndromic orofacial clefts and 88 infants without a congenital malformation and from their mothers at approximately 14 months after the index pregnancy. Red blood cell and serum folate, serum vitamin B(12), whole blood vitamin B(6) as pyridoxal-5'-phosphate (PLP), and plasma homocysteine concentrations were measured.

Results: A vitamin B(12) concentration of 185 pmol/L or less and a PLP concentration of 44 nmol/L or less in mothers increased the risk of having a child with an orofacial cleft (odds ratio [OR]=3.1; 95% CI: 1.3-7.4, OR=2.9; 95% CI: 1.2-7.1, respectively). Infants with orofacial clefts had a 15% lower serum folate concentration compared with controls (P=.06).

Conclusion: A low vitamin B(12) and PLP concentration in mothers increased the risk of orofacial clefts in the offspring. A possible role of the infant's folate status is suggested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cleft Lip / etiology*
  • Cleft Palate / etiology*
  • Female
  • Folic Acid / blood
  • Homocysteine / blood*
  • Humans
  • Infant
  • Mothers
  • Pyridoxal Phosphate / blood
  • Risk Factors
  • Vitamin B 12 / blood*
  • Vitamin B 6 / blood*

Substances

  • Homocysteine
  • Pyridoxal Phosphate
  • Vitamin B 6
  • Folic Acid
  • Vitamin B 12